Blepharitis is described as a common chronic inflammatory condition affecting the eyelid margins, and it can be linked to systemic conditions, especially rosacea and seborrheic dermatitis. It is also described as multifactorial, with a complex pathophysiology that is not fully understood, which contributes to heterogeneity in clinical presentation and management strategies. Blepharitis is characterized by inflammation of the eyelid margin and is reported to occur among people of all ages, ethnicity, and sex. In the same review, blepharitis is described as generally not sight threatening, while untreated disease is stated to have the potential to cause keratopathy, corneal neovascularization and ulceration, and permanent alterations in eyelid morphology.

A common clinical framing subdivides blepharitis into anterior and posterior forms, while acknowledging considerable overlap between categories. Putnam discusses anterior blepharitis as infectious and seborrheic, and uses posterior blepharitis to encompass meibomian gland dysfunction (MGD). Guillon and colleagues further emphasize that posterior blepharitis and MGD have been erroneously used synonymously, describing two different clinical entities that often coexist in practice. This coexistence is clinically relevant because posterior lid margin involvement is tied to meibomian gland secretion, which forms the outer lipid layer of the tear film, and dysfunction in this system is linked to evaporative dry eye and eyelid margin inflammation.

For anterior blepharitis, the “Uncommon Blepharitis” review describes it as usually infectious, identifying Staphylococcus aureus as the most common organism responsible, and also states an association with seborrheic dermatitis.² Putnam’s review similarly reports that multiple bacteria are present in anterior blepharitis and specifies Staphylococcus epidermidisas the most commonly identified species, followed by Staphylococcus aureus and other genera. Guillon’s paper also states that anterior blepharitis is usually associated with staphylococcal or seborrheic contamination of the eyelid margin and lashes. In terms of clinical expression, Putnam lists symptoms that may include superficial discomfort, mild photophobia, collarettes with lash debris, lid margin hyperemia, lid ulceration, madarosis, and trichiasis.

Putnam frames infection and inflammation as primary contributors to blepharitis and highlights that overlap among classifications can contribute to variability and misdiagnosis. Within anterior blepharitis, Putnam outlines three convergent pathways likely underlying pathophysiology: direct bacterial infection, exotoxin hypersensitivity, and delayed cell mediated immune hypersensitivity response. This model aligns with the broader view that blepharitis is not a single entity but a clinical syndrome that can reflect different upstream drivers across patients.

Posterior blepharitis is described as caused by meibomian gland dysfunction, with meibomian lipids forming the outer tear film layer. In Sheppard’s review, MGD is described as the leading cause of evaporative dry eye disease, characterized by reduced meibum secretion and or altered meibum composition, disrupting the tear film lipid layer and increasing tear evaporation. Xie and colleagues similarly state that MGD is the most common etiology of evaporative dry eye and note that lid hygiene is suggested in the context of terminal duct obstruction. Together, these sources support a conceptual link in which lid margin inflammation and tear film instability can be mutually reinforcing features within posterior lid disease patterns.

Demodex associated blepharitis is addressed explicitly in Rhee’s review, which describes Demodex mites as contributing to blepharitis through direct mechanical damage, acting as a vector for bacteria, and inducing hypersensitivity and inflammation. The same abstract lists risk factors including increasing age, rosacea, and diabetes, and describes collarettes as pathognomonic for Demodex blepharitis. Putnam also notes that parasitic infection from the Demodex genus has been implicated in more chronic forms of blepharitis. These statements support including Demodex as a distinct and clinically important contributor within the broader blepharitis spectrum, especially in chronic or recurrent presentations described in the literature.

Across sources, eyelid hygiene is repeatedly positioned as foundational in blepharitis management. Putnam describes primary treatment as lid hygiene involving a hyperthermic lid compress, lid margin massage, and lash scrubs, and further explains that hyperthermia is critical to soften meibomian secretions to improve gland expression while lash scrubs help remove accumulated debris. Evidence consistent with this approach is provided by Guillon’s prospective interventional study evaluating eyelid hygiene with formulated wipes in patients with anterior blepharitis or MGD, which reports significant improvements in eyelid margin status including endpoints related to eyelash contamination, meibomian gland blockage, and meibomian gland expression, using an intensive phase followed by a maintenance phase. The same paper explicitly states that the dual phase approach achieved rapid improvement and that improvements were maintained with continued management.

When a staphylococcal pattern is suspected, Putnam states that staphylococcal blepharitis may show a strong response to topical antibiotic ointment therapy after lid hygiene and lists erythromycin or bacitracin as options, with treatment duration described as dependent on clinical severity. For posterior blepharitis and MGD not well controlled with lid hygiene, Putnam states that oral tetracyclines or macrolides may be effective. These statements are presented as part of a pragmatic management framework in which baseline lid hygiene is supplemented by targeted therapy when clinical patterns suggest bacterial involvement or when posterior disease remains active.

Two randomized clinical trials in PubMed Central report quantitative outcomes for hypochlorous acid based eyelid hygiene strategies, and their findings can be summarized discursively without repeating numeric endpoints. In Mencucci’s prospective randomized study comparing a hypochlorous acid hygiene solution with hyaluronic acid wipes, the Results text states that tear film breakup related measures significantly increased in the hypochlorous acid group while not showing a statistically significant difference in the comparator group for those same measures, and it also reports significant changes in symptom and ocular surface related variables across groups. In Zhang’s randomized clinical trial evaluating hypochlorous acid delivered through ultrasonic atomization, the Results section reports significant improvement in a symptom questionnaire score and describes significant improvements in lid margin and meibum related parameters. Taken together, these studies support that hypochlorous acid based hygiene approaches have been associated with statistically significant improvements in both symptoms and selected clinical signs over relatively short follow up periods, while also illustrating that endpoints and delivery modalities differ across trials.

For Demodex blepharitis, the Cochrane review by Pucker and colleagues concludes that there is uncertainty regarding the effectiveness of tea tree oil for short term treatment across the studied concentrations and notes irritation considerations, with lower concentrations discussed as potentially preferable to reduce induced ocular irritation. The same review reports that included trials had risk of bias concerns, limiting confidence in estimated effects. These conclusions support a cautious interpretation of tea tree oil evidence in Demodex blepharitis, with uncertainty stemming from variability and methodological limitations in the randomized trial literature.

Limitations of the overall evidence base are explicitly acknowledged across the included sources. Blepharitis is repeatedly characterized as multifactorial and not fully understood, and Putnam reports that a review of studies concluded little evidence exists to support a curative or universal approach, describing long term management as centered on lid hygiene with focal treatment of exacerbations. In addition, Xie and colleagues state that although lid margin cleaning plays an important role in the treatment of MGD, a standardized method that is safe and effective has not yet been fully established, and they note that baby shampoo, described as a common method, can potentially trigger allergies or cause ocular discomfort. This combination of multifactorial pathophysiology, overlapping phenotypes, and heterogeneous interventions helps explain why management in the literature is often described as individualized and iterative rather than uniform across all patients.

Overall, the allowed sources support a practical, evidence anchored narrative: blepharitis is a common chronic eyelid margin inflammatory condition with overlapping anterior and posterior patterns, frequently linked to microbial, inflammatory, meibomian gland, and Demodex related contributors, and commonly managed with eyelid hygiene as a baseline strategy supplemented by targeted therapies when clinical patterns and response warrant. Where interventional studies and randomized trials are available, they report statistically significant improvements in selected symptoms and signs for specific hygiene approaches, but the literature also emphasizes uncertainty, heterogeneity, and the absence of a universally curative strategy.

References

Putnam, C. M. Diagnosis and management of blepharitis: an optometrist’s perspective. Clinical Optometry (2016). PMCID: PMC6095371.Di Zazzo, A. et al. Uncommon Blepharitis (2024). PMCID: PMC10856592.Rhee, M. K. et al. Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies (2023). PMCID: PMC10351901.Pucker, A. D. et al. Tea tree oil for Demodex blepharitis. Cochrane Database Syst. Rev. (2020). PMCID: PMC7388771.Mencucci, R. et al. Hypochlorous acid hygiene solution in patients affected by blepharitis: a prospective randomised study (2023). PMCID: PMC10711848.Zhang, Y. et al. Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial (2023). PMCID: PMC9917691.Sheppard, J. D. et al. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape (2023). PMCID: PMC10164226.Guillon, M., Maissa, C. & Wong, S. Eyelid Margin Modification Associated With Eyelid Hygiene in Anterior Blepharitis and Meibomian Gland Dysfunction. Eye & Contact Lens 38, 319–325 (2012).
Xie, X. et al. (Deep clean JZUSB20-0679 ing context for MGD associated dry eye). J Zhejiang Univ Sci B 20(8), 679–686 (2019).